AnalystsSwapnil MalekarSwapnil Malekar's Stock Forecasts
AnalystsSwapnil Malekar
Sectors:
Industries:
Analyst Ranking
Bottom 19%
#3744 out of 4563 analysts
Average Return
-12.53%
Win Rate
50%3 out of 6
Risk vs Reward
Poor
Good
Swapnil Malekar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mirati Therapeutics IncMRTX | +58.65% | $37.00 | $58.70 | 2023-08-09 - 2024-01-22 | Strong Buy |
Mirati Therapeutics IncMRTX | +35.33% | $41.97 | $56.80 | 2022-12-13 - 2023-12-12 | Strong Buy |
Mirati Therapeutics IncMRTX | +29.28% | $43.85 | $56.69 | 2022-12-08 - 2023-12-07 | Strong Buy |
Swapnil Malekar Analyst Color
Get additional color on Swapnil Malekar's coverage of popular stocks
Swapnil Malekar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mirati Therapeutics IncMRTX | 4 | Strong Buy | $45.00 | -23.34% | Assumes | 9 months ago |
Ngm Biopharmaceuticals IncNGM | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Immuneering CorpIMRX | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | 2 years ago |
Intellia Therapeutics IncNTLA | 1 | Strong Buy | $171.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.